Aflatoxin and ochratoxin production by Aspergillus species under ex vivo conditions

Maren A Klich1, Sean Tang, David W Denning

  • 1USDA, ARS, Southern Regional Research Center, New Orleans, LA 70124, USA. maren.klich@ars.usda.gov

Mycopathologia
|June 23, 2009
PubMed

Insights

Aflatoxin is unlikely to be a virulence factor in aspergillosis, as it was not produced on human tissue-mimicking media. Ochratoxin, however, may be a potential virulence factor in aspergillosis.

Area of Science:

  • Medical Mycology
  • Pathogen Toxinology

Background:

  • Aspergillus species are emerging as significant human pathogens.
  • The role of toxic metabolites as virulence factors in aspergillosis remains largely uncharacterized.

Purpose of the Study:

  • To investigate the potential of aflatoxin and ochratoxin as virulence factors in aspergillosis.
  • To assess toxin production by Aspergillus species under ex vivo conditions.

Main Methods:

  • Screening of aflatoxin and ochratoxin-producing Aspergillus isolates.
  • Toxin production assays were performed on yeast extract sucrose agar (YES) and brain heart infusion agar (BHA) at physiological temperatures (35°C and 37°C).
  • BHA was modified with altered pH and sugar levels to simulate human tissue conditions.

Main Results:

  • Aflatoxin production was detected in 7/21 isolates on YES at 35°C and 37°C, but not on BHA or modified BHA.
  • Ochratoxin was produced by 6/12 isolates on YES at 35°C.
  • Significant ochratoxin production was observed from Aspergillus alliaceus on BHA and modified BHA at 37°C, with one Aspergillus pseudoelegans strain producing a minor amount.

Conclusions:

  • Aflatoxin is unlikely to function as a virulence factor in aspergillosis due to its inability to be produced on human tissue-mimicking media.
  • Ochratoxin demonstrates potential as a virulence factor in aspergillosis, given its production under simulated physiological conditions.